ReShape Lifesciences (HIND) Profit Margin (2015 - 2026)
ReShape Lifesciences (HIND) profit margin from Sep 30, 2015 to Mar 31, 2026. The current ReShape Lifesciences (HIND) profit margin is -3200.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of ReShape Lifesciences (HIND)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -3206.25% | +17611.77% |
| 2024 | -18.10% | -86.20% |
| 2023 | -131.22% | -68.08% |
| 2022 | -411.12% | -11.46% |
| 2021 | -464.34% | +142.58% |
| 2020 | -191.42% | -73.49% |
| 2019 | -721.95% | +75.76% |
| 2018 | -410.77% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | -350.76% | +6.72% |
| 2017 | -328.67% | -16.66% |
| 2017 | -394.39% | -25.10% |
| 2017 | -526.53% | -12.80% |
| 2016 | -603.83% | -11.61% |
| 2016 | -683.12% | +29.01% |
| 2016 | -529.49% | +58.25% |
| 2016 | -334.58% | -13.13% |
| 2015 | -385.15% | +17.92% |
| 2015 | -326.61% | -31.69% |
| 2015 | -478.10% | +104.26% |
| 2015 | -234.07% | -16.22% |
| 2014 | -279.38% | N/A |
Comparison ReShape Lifesciences (HIND) profit margin with competitors
ReShape Lifesciences (HIND) profit margin is -3200.00%.